Investors

BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization.

BioLineRx's leading therapeutic candidates are: BL-8040, a cancer therapy platform, which has successfully completed a Phase 2a study for relapsed/refractory... read more

Upcoming Events View all

December 5, 2019

Investor Breakfast 2019

January 13, 2020

Biotech Showcase

I.R. Contacts

If you would like further information or have questions or comments, please contact:

Tim McCarthy
LifeSci Advisors, LLC
+1-212-915-2564
tim@lifesciadvisors.com

Media inquiries:

Tsipi Haitovsky
Public Relations
+972-52-598-9892
tsipih@netvision.net.il